Recce Net Income from 2010 to 2026
| RCE Stock | 0.56 0.01 1.75% |
Net Loss | First Reported 2012-12-31 | Previous Quarter -7.7 M | Current Value -13.7 M | Quarterly Volatility 3.5 M |
Check Recce Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Recce Pharmaceuticals' main balance sheet or income statement drivers, such as Interest Expense of 1.5 M, Cost Of Revenue of 12.6 M or Depreciation And Amortization of 128.2 K, as well as many indicators such as . Recce financial statements analysis is a perfect complement when working with Recce Pharmaceuticals Valuation or Volatility modules.
Recce | Net Income |
The evolution of Net Income for Recce Pharmaceuticals provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Recce Pharmaceuticals compares to historical norms and industry peers.
Latest Recce Pharmaceuticals' Net Income Growth Pattern
Below is the plot of the Net Income of Recce Pharmaceuticals over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Recce Pharmaceuticals financial statement analysis. It represents the amount of money remaining after all of Recce Pharmaceuticals operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Recce Pharmaceuticals' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Recce Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (21.43 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Recce Net Income Regression Statistics
| Arithmetic Mean | (7,795,248) | |
| Coefficient Of Variation | (100.52) | |
| Mean Deviation | 7,024,286 | |
| Median | (4,316,737) | |
| Standard Deviation | 7,835,505 | |
| Sample Variance | 61.4T | |
| Range | 21.2M | |
| R-Value | (0.92) | |
| Mean Square Error | 9.9T | |
| R-Squared | 0.85 | |
| Slope | (1,430,155) | |
| Total Sum of Squares | 982.3T |
Recce Net Income History
About Recce Pharmaceuticals Financial Statements
Recce Pharmaceuticals shareholders use historical fundamental indicators, such as Net Income, to determine how well the company is positioned to perform in the future. Although Recce Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. The changes in Recce Pharmaceuticals' assets and liabilities, for example, are also reflected in the revenues and expenses on on Recce Pharmaceuticals' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Recce Stock Analysis
When running Recce Pharmaceuticals' price analysis, check to measure Recce Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Recce Pharmaceuticals is operating at the current time. Most of Recce Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Recce Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Recce Pharmaceuticals' price. Additionally, you may evaluate how the addition of Recce Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.